TrialArthritis research & therapy2017

Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis.

Huayong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.